Haleos Labs Ltd

Ticker: SMSLIFE
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
1132.50
Market Cap
342.39
Debt/Equity
0.4075
ROE %
9.914
PB
1.6147
Promoter %
71.405
Pledge %
0.000
1Y Rev Growth %
12.847
5Y Rev Growth %
5.852
NP Margin %
5.752
NP Margin 5Y Avg %
4.854

Trading Reference

1M Return %
-5.095
6M Return %
-0.106
1Y Return %
-30.545
% Away 52W High
49.227
% Away 52W Low
17.993
Daily Volume
180
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Haleos Labs Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a strong potential for upward movement. However, if it falls below the support, it could face significant downside risk.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Haleos Labs Ltd is a pioneering company focused on developing innovative healthcare solutions tailored for the Indian market. With a commitment to enhancing patient outcomes, Haleos Labs leverages cutting-edge technology and research to create products that cater to diverse healthcare needs. This makes it an essential partner for healthcare providers and patients alike, aiming to improve overall well-being. Their dedication to quality and efficacy positions them as a trusted name in the industry, making healthcare more accessible and effective for all.

  • Innovative healthcare solutions
  • Tailored for the Indian market
  • Focus on enhancing patient outcomes
  • Leverages cutting-edge technology
  • Trusted name in the industry
  • Committed to quality and efficacy

Investment Thesis

Haleos Labs Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a promising choice for investors seeking long-term gains.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Rapid growth in digital services sector offers substantial revenue potential.
  • Valuation metrics indicate Haleos Labs is undervalued compared to industry peers.
  • Strategic initiatives in technology adoption position the company for future success.
  • Commitment to innovation ensures competitive advantage in a dynamic market.

Opportunity vs Risk

Opportunities
  • Growing demand for health supplements
  • Strong online sales growth
  • Expansion into international markets
  • Innovative product launches
  • Strategic partnerships with retailers
Risks ⚠️
  • Intense competition in the sector
  • Regulatory changes affecting sales
  • Supply chain disruptions
  • Dependence on key suppliers
  • Market volatility impacting stock price

Peer Perspective

Haleos Labs Ltd trades at a slight premium compared to peers like Biocon and Dr. Reddy's, reflecting its growth potential. A sustained improvement in margin stability could trigger a favorable rerating.

Future Outlook

Haleos Labs Ltd is well-positioned for growth, driven by innovative product development and expanding market reach; however, successful execution and effective cost control will be crucial to realizing its full potential.

AI FAQs for Retail Users

  • Q: What does Haleos Labs Ltd do?
    A: Haleos Labs Ltd specializes in biotechnology and pharmaceutical research and development.
  • Q: Is Haleos Labs Ltd a profitable company?
    A: Profitability can vary; please check recent financial reports for updated information.
  • Q: What are the risks of investing in Haleos Labs Ltd?
    A: Risks include market volatility, regulatory changes, and company-specific challenges.
  • Q: How can I buy shares of Haleos Labs Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: Where can I find more information about Haleos Labs Ltd?
    A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Haleos Labs Ltd • Updated: 2025-09-17 02:18:49
  • 8
    Business
    High
    The sector is emerging with potential, but competition is increasing.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with some fluctuations in profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are moderate, but OCF is not consistently strong.
  • 9
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity could be improved.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns about pledging.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks are significant.
  • 1
    Technicals
    Low
    Market sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100 • Risky
Haleos Labs Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.